Filter by: patients
What is Methenamine Hippurate?

Methenamine Hippurate is an antibiotic used in the prevention or suppression of recurrent urinary tract infections and for the treatment of urinary tract discomfort related to excessive motility of the urinary tract.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Bladder problems 6 1 Efficacy_cant_tell
Prevent infection 4 0
Urinary Tract Infection UTI 2 0
Other 1 0

See all 12 patients currently taking Methenamine Hippurate

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
1
None
1

Commonly reported side effects, conditions, and hospitalizations associated with Methenamine Hippurate

Yeast Infection (candida) 1

Reported Dosages

  1 g daily 2 g daily 3 g daily
  4 Number of Patients: 4 7 Number of Patients: 7 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Methenamine Hippurate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 1   Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Methenamine Hippurate

Currently Taking Methenamine Hippurate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Methenamine Hippurate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Methenamine Hippurate

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Methenamine Hippurate

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

Cost of Methenamine Hippurate

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.